Case Report
Feminizing Adrenal Carcinoma Presenting with Heart Failure and Ventricular Tachycardia
Table 2
Hormonal evaluation.
| | Pre-operation | Immediately postoperation | At 15-month followup | Reference Range |
| ACTH (pg/mL) | <5 | | | 7–50 | AM cortisol (μg/dL) | 27.7 | | | | Cortisol after overnight 1 mg dexamethasone suppression (μg/dL) | 23.6 | | | <1.8 | Androstenedione (ng/dL) | 375 | | | 50–220 | DHEA-S (μg/dL) | 726 | 39 | | 25–240 | Plasma metanephrine (pg/mL) | <25 | | | ≤57 | Plasma normetanephrine (pg/mL) | <25 | | | ≤148 | Total metanephrines (pg/mL) | <50 | | | ≤205 | Aldosterone (ng/dL) | <1 | | | ≤28 (upright 8 am–10 am) | Plasma renin activity (ng/mL/hr) | 2.8 | | | 0.65–5.0 (upright) | Estradiol (pg/mL) | 3853 | <30 | 25.2 | <52 (males) | 24 hr urine free cortisol (mcg/24 hrs) | 56.7 | Not measured | Not measured | 4.0–50.0 | 24 hr urine volume (mL) | 2080 | | | |
|
|